Health Risks of Peptides in Bodybuilding
Peptides in Bodybuilding
5-75% purity range
Independent testing of falsified peptide drugs from online pharmacies found purity as low as 5%, with arsenic at 10x the safety limit for injectables.
Janvier et al., Talanta, 2018
Janvier et al., Talanta, 2018
View as imagePeptide use in bodybuilding has grown rapidly. Surveys suggest use among gym members may reach 29%, yet only about 38% of users recognize the associated health risks. Most peptides used in this context have never been tested in human clinical trials for the purposes bodybuilders use them. The products themselves are frequently purchased from unregulated online sources, injected without medical oversight, and combined in untested protocols. The broader culture of peptide use in bodybuilding is driven by perceived benefits in muscle growth, fat loss, and recovery, but the evidence base for safety is thin to nonexistent for most compounds and use patterns.
Key Takeaways
- Falsified peptide drugs sold online showed purity as low as 5%, with arsenic concentrations up to 10x the ICH safety limit for injectable drugs (Janvier et al., 2018)
- A case report of combined LGD-4033 and MK-677 use documented total testosterone dropping 62%, free testosterone dropping 85.7%, and ALT increasing 205% (Cardaci et al., 2022)
- Only 3 pilot studies have examined BPC-157 in humans as of 2025, none with rigorous safety monitoring or large sample sizes
- MK-677 at 25 mg daily increased fasting glucose from 5.4 to 6.8 mmol/L in healthy elderly subjects over 4 weeks (Chapman et al., 1996)
- Glycine-modified analogs of GHRP-2, GHRP-6, and ipamorelin have been identified in seized doping materials, designed to evade detection (Gajda et al., 2019)
- All growth hormone secretagogues, SARMs, and most bodybuilding peptides are classified as unapproved drugs by the FDA and banned by WADA
Product Contamination: What Is Actually in the Vial
The most immediate health risk is not the peptide itself but what comes with it. Most bodybuilding peptides are purchased from unregulated online vendors selling products labeled "for research purposes only" or "not for human consumption." These labels exist specifically to circumvent pharmaceutical regulations.
Janvier et al. (2018) conducted the most systematic analysis of this problem. They profiled the ten most frequently encountered falsified peptide drugs on the Belgian market, purchased from three suspected illegal online pharmacies. The findings were alarming.[1]
Purity ranged from 5% to 75% for cysteine-containing peptides. This means that in the worst cases, 95% of the injected material was not the intended drug but unknown impurities, degradation products, and contaminants. Multiple samples contained arsenic at concentrations up to ten times the International Council for Harmonisation (ICH) toxicity limit for parenteral (injectable) drugs. All arsenic was present in its most toxic inorganic form, as confirmed by speciation analysis. One sample was also contaminated with lead.
The implications for bodybuilders injecting these products daily or multiple times per week are significant. Arsenic is a known carcinogen that accumulates in tissues. Lead causes neurological damage at chronic low doses. Neither is detectable by the user through taste, appearance, or immediate symptoms.
The variation in drug content per vial adds another risk layer. Users who dial in a perceived "effective dose" from one batch may be injecting a drastically different amount from the next. This inconsistency makes it impossible to manage dose-dependent side effects.
Hormonal Disruption: The Case Report Evidence
Cardaci et al. (2022) published a detailed case report of a 25-year-old male who co-administered LGD-4033 (10 mg daily) and MK-677 (15 mg daily) for 5 weeks.[2] The results documented what many bodybuilding forums dismiss as minor side effects:
- Total testosterone dropped 62.3%
- Free testosterone dropped 85.7%
- Sex hormone-binding globulin dropped 79.6%
- Follicle-stimulating hormone fell below clinical reference values (1.2 IU/L)
- ALT (liver enzyme) increased 205%
- AST increased 95.8%
- LDL cholesterol increased 40.0%
- HDL cholesterol decreased 36.4%
- Triglycerides increased 39.2%
- Bone mineral density decreased 2.1%
While body mass increased 6.0% and lean mass increased 3.1%, the hormonal and metabolic costs were substantial. Most variables returned to baseline after cessation, but total cholesterol, LDL, total fat mass, and bone area had not fully recovered by the post-cycle measurement.
This is a single case report, which limits generalizability. But the magnitude of the hormonal suppression (approaching levels seen with anabolic steroid use) and the liver enzyme elevation (ALT tripled) represent concrete, documented harm.
Metabolic Side Effects of GH Secretagogues
MK-677 (ibutamoren) is among the most popular bodybuilding peptides for body composition, but its metabolic effects receive less attention than its GH-boosting properties.
Chapman et al. (1996) documented that daily oral MK-677 at 25 mg increased fasting glucose from 5.4 to 6.8 mmol/L in 32 healthy subjects aged 64-81 over 4 weeks.[5] A fasting glucose of 6.8 mmol/L crosses the threshold for impaired fasting glucose and approaches diabetic range. This occurred in only 4 weeks at standard doses.
GH itself is diabetogenic. It promotes hepatic glucose output and reduces peripheral insulin sensitivity. Any compound that substantially raises GH levels (MK-677, GHRP-2, GHRP-6, ipamorelin, CJC-1295) has the potential to impair glucose metabolism. Bodybuilders who use these compounds for months or years may be accumulating metabolic damage that is not immediately apparent but contributes to long-term insulin resistance risk.
Other common side effects of GH secretagogues include water retention (edema), joint pain (arthralgia), increased appetite (particularly with GHRP-6), numbness and tingling in extremities, and fatigue. These are dose-dependent and typically worsen with prolonged use.
Murphy et al. (1998) showed MK-677 reversed nitrogen wasting during caloric restriction, demonstrating genuine anti-catabolic effects.[7] But this 7-day study in 8 subjects did not assess metabolic consequences of sustained use, the typical bodybuilding context where MK-677 is taken for 8-16 weeks continuously.
BPC-157: The Human Evidence Gap
BPC-157 (Body Protection Compound-157) is one of the most widely used peptides in bodybuilding circles, primarily for injury recovery. Its popularity is built on extensive animal research showing tissue repair, angiogenesis, and anti-inflammatory effects. The gap between this preclinical evidence and the human safety data is enormous.
McGuire et al. (2025) published a narrative review titled "Regeneration or Risk?" that surveyed the entire BPC-157 literature.[4] They found only three pilot studies had examined BPC-157 in humans as of 2025: one for intraarticular knee pain, one for interstitial cystitis, and one for intravenous safety/pharmacokinetics. No adverse effects were reported across these small studies, but none had rigorous safety monitoring, adequate sample sizes, or follow-up periods that would satisfy regulatory standards.
The IV safety pilot (Lee et al., 2025) tested BPC-157 infusions of up to 20 mg in just 2 healthy adults. No adverse effects were observed, but a 2-person study cannot detect any adverse event occurring at a rate lower than 50%.[3]
The practical reality is that thousands of bodybuilders inject BPC-157 daily based on animal data and anecdotal reports. The compound's theoretical risk profile includes effects on angiogenesis and growth factor signaling. Whether BPC-157 could promote tumor angiogenesis or affect wound healing in ways that matter for cancer risk over years of use is unknown. The absence of evidence for harm is not evidence of absence.
For a deeper look at BPC-157's evidence base, see BPC-157: what the research shows and BPC-157 and TB-500 in bodybuilding.
Injection-Related Risks
Bodybuilders self-administering injectable peptides face risks that go beyond the compound's pharmacological effects:
Infection. Non-sterile injection technique, contaminated vials, and reuse of needles create infection risk. Case reports document abscesses, cellulitis, and in severe cases, compartment syndrome requiring surgical intervention. Blood-borne pathogen transmission (HIV, hepatitis B and C) has been documented among users sharing injection equipment.
Injection site reactions. Subcutaneous peptide injections commonly cause localized pain, redness, and swelling. With repeated injections at the same site, lipodystrophy (localized fat tissue changes) can develop.
Incorrect dosing. Reconstituting lyophilized peptide powder requires precise measurement. Errors in reconstitution, combined with the purity variation documented by Janvier et al., mean users frequently inject doses that differ substantially from their intended target.[1]
Polypharmacy. Bodybuilders rarely use a single peptide. Common stacks combine multiple GH secretagogues (e.g., CJC-1295 + ipamorelin + MK-677), healing peptides (BPC-157 + TB-500), and sometimes anabolic steroids and insulin simultaneously. No drug interaction data exists for these combinations. The Cardaci case report documented effects from just two compounds combined. Real-world bodybuilding protocols often involve four or more simultaneous substances, creating pharmacological interactions that have never been studied in any context.
Storage and handling. Many peptides are shipped as lyophilized powder requiring refrigerated storage and sterile reconstitution with bacteriostatic water. Temperature excursions during shipping, improper storage, and non-sterile reconstitution can degrade the peptide, create bacterial contamination, or both. Users have no way to verify whether a reconstituted peptide retains its intended biological activity or has degraded into inactive or potentially harmful fragments.
Modified Peptides and Detection Evasion
Gajda et al. (2019) identified a concerning trend: glycine-modified analogs of GHRP-2, GHRP-6, ipamorelin, and modified GRF 1-29 in seized doping materials.[6] Each had an extra glycine amino acid added at the N-terminus, specifically designed to evade anti-doping detection methods while presumably maintaining biological activity.
These designer modifications create compounds with zero pharmacological or safety data. Users who purchase "GHRP-2" from underground sources may actually receive a glycine-modified analog with unknown receptor binding characteristics, unknown metabolism, and unknown toxicity. The modification may alter half-life, receptor selectivity, and off-target effects in ways that are completely unpredictable.
The Regulatory Landscape
The FDA does not approve BPC-157, TB-500, MK-677, GHRP-2, GHRP-6, ipamorelin, or CJC-1295 for any indication. In 2023, the FDA specifically added several peptides, including BPC-157, to its list of bulk drug substances that may present significant safety risks, effectively restricting compounding pharmacies from preparing them.
WADA prohibits all growth hormone secretagogues (GHRPs, GHRH analogs, MK-677) and most peptides used in bodybuilding at all times, in and out of competition.
The legal reality for users: these are unapproved drugs, not supplements. Purchasing them requires navigating a market where quality control is absent, labeling is unreliable, and legal protections do not apply.
What the Evidence Actually Supports
Honest assessment of the evidence requires separating three distinct questions:
Do these peptides have biological effects? Yes. MK-677 raises GH and IGF-1 reliably.[5] BPC-157 promotes tissue repair in animal models.[4] These are biologically active compounds, not inert placebos.
Are they safe for the way bodybuilders use them? Unknown. No study has tested multi-month stacking protocols, the typical bodybuilding use pattern. The case report data that exists documents concerning hormonal and metabolic effects.[2]
Are the products bodybuilders purchase what they claim to be? Frequently, no. Purity as low as 5% and arsenic at 10x safety limits have been documented in products from the exact type of online sources bodybuilders use.[1]
The combination of biologically active compounds, absent safety data, and contaminated supply chains creates a risk profile that is poorly characterized but plainly not benign. The literature does not support the claim that bodybuilding peptides are "safe" because they are "natural" or because they mimic endogenous compounds. Insulin is a natural hormone that kills people when misused. Growth hormone is an endogenous compound that causes acromegaly at excess levels. The fact that a peptide exists naturally in the body tells you nothing about the safety of injecting its synthetic analog at supraphysiological doses for months.
The Bottom Line
The documented health risks of peptide use in bodybuilding fall into three categories: product contamination (purity as low as 5%, toxic metal contamination), pharmacological side effects (hormonal suppression, insulin resistance, liver enzyme elevation), and injection-related complications. Human safety data for most bodybuilding peptides ranges from minimal (MK-677) to essentially absent (BPC-157, TB-500). The case report literature documents significant hormonal disruption from compounds assumed to be relatively benign. The unregulated supply chain adds contamination risks that are independent of the peptide's own pharmacology.